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ABSTRACT 
Biophysical procedures have been used  to determine the size and structure of 
the  biologically active agent  responsible  for  the  transmission,  through  milk, of 
mouse mammary adenocarcinoma. Filtration of milk from RIII high-breast-cancer 
mice  through  gradocol  membranes  with  decreasing pore  sizes  indicated  that  a 
minimum  of activity passed  through  intermediate pore  sizes  (100  to  160  m/z). 
Filtrates through smaller pores were significantly active. Milk treated with small 
doses of deuteron irradiation produced more tumors than the control, unirradiated 
milk; larger doses indicated a particle size much less than 100 m/z. Free diffusion 
experiments indicated that the activity was associated with particles of two differ- 
ent sizes. Altogether the data denoted the presence of a large agent about 100 m# 
in diameter and a small agent 20 to 30 m/z in diameter or possibly smaller.  Further- 
more, the presence in the milk of an inhibitor 40 to 60 In# is indicated by the re- 
sults of all three approaches.  The complex nature of the milk agent disclosed  by 
the physical measurements agrees with the picture of one of the structures revealed 
by electron microscopy  as well as with seemingly conflicting measurements reported 
in the literature.  The large agent defined by these indirect methods corresponds 
to the whole particle seen in the electron microscope and  the small agent corre- 
sponds to its internal core or nucleoid. It is suggested that the nucleoid is essen- 
tially a nucleic acid which may, in the absence of the "inhibitor," retain its activity 
after being stripped of its outer membrane or sac. 
The  establishment  of  genetically  homozygous 
strains  of mice with  high  and  with  low incidence 
of mammary  tumors has permitted  extensive bio- 
logical  studies  of  mammary  adenocarcinoma  by 
reciprocal cross-breeding and  foster nursing  (1-3). 
Since Bittner  (3)  demonstrated  that an extrachro- 
mosomal carcinogenic factor was conveyed through 
the  milk  of  high-cancer-strain  females  many  at- 
tempts  have been made  to characterize  or  to iso- 
late  the milk agent.  Passey et al. (4)  prepared  ex- 
tracts  from  malignant  and  normal  tissues  from 
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mice of the C3H,  Strong A, and  RIII high-cancer 
strains  by drying  the  tissue,  treating  with  petro- 
leum  ether,  extracting  with  distilled water,  then 
treating the extract with trypsin for 30 minutes at 
37 °,  and  filtering  through  Berkefeld  N  candles. 
Dispersions of these preparations  examined in the 
electron  microscope  indicated  a  predominance  of 
particles 15 to 35 m~ in diameter which were active 
in assay mice, whereas extracts similarly prepared 
from  tissues  of  low  cancer  strains  or from  chem- 
ically induced  tumors  contained  neither  the char- 
acteristic particles nor did they produce tumors in 
assay mice. By ultracentrifugation of preparations 
from high-cancer strains  they reported that super- 
natants  could be  obtained  which were free of the 
15  to 35 m# particles and  were concomitantly de- 
void  of  activity.  These  experiments  indicated  a 
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high  degree  of  correlation  between  the  presence 
of characteristic particles revealed by electron mi- 
croscopy in milk extracts and the latter's ability to 
induce tumors. 
While these experiments were being carried on in 
Leeds, Porter and Thompson (5) reported the pres- 
ence  of  130  mg  bodies  associated  with  epithelial 
cells cultured from the high-cancer strain, C3H tu- 
mors.  These  bodies  could  be  seen  in  great  abun- 
dance in the whole mounts of thin epithelial cells 
which  were  examined  in  the  electron  microscope 
without embedding  and  sectioning.  Close  exami- 
nation of these bodies indicated that they were com- 
plex in structure consisting of a  dense central por- 
tion approximately 75 nag in diameter, surrounded 
by a less dense zone. One year later Graft et al.  (6) 
reported  on the isolation of  the mouse mammary 
carcinoma virus from RIII milk. In this report the 
purified agent was found  to form two sedimenting 
boundaries  in  the  analytical  ultracentrifuge,  one 
sharp  with  a  sediment  constant  of 900S,  and  the 
other  diffuse  with  a  sediment  constant  of  500  to 
700S.  Dispersions  of these preparations  contained 
particles from under 50 to over 100 mg in diameter, 
the  predominant  size  being  about  100  m#,  The 
preparations  were thought  to contain nucleic acid 
because their absorption curves showed a hump at 
2600  A.  No  similar  substance  was  obtained  from 
milk of C57 agent-free mice except when they were 
foster-nursed on RIII agent-bearing mothers. 
After it became possible to section tissue suitably 
for  electron  microscopy,  mammary  tumors  from 
agent-bearing mice were found to contain a variety 
of virus-like particles (7-12). One variety, measur- 
ing about 65 mg in diameter, consisted of a  dense 
shell with  a  less dense  homogeneous  interior  and 
was found mostly in the Golgi region of the cyto- 
plasm of ceils (8,  10).  Another variety consisted of 
a  well  defined  thin-walled  spherical  sac  with  an 
average diameter of about 100 mg which contained 
an  inner  very  dense  body,  centered  or  excentric, 
measuring 20 to 35 mg (7-12). These were found in 
the intercellular spaces and pictorial evidence sug- 
gested that they were formed by a budding process 
at  the  cell membrane. 
The  experiments  and  observations  reported  in 
this paper  have involved the use of different pro- 
cedures  for  correlating  activity with  particle  size 
and form, and were made in an effort to determine 
which, if any, of the several particles observed pos- 
sess the ability to induce mammary  cancer and  is 
indeed  the milk agent. 
Materials and Methods 
Mouse  Colonies,--Milk  from  the  Columbia  Uni- 
versity Colony of RIII mice was used as the source of 
the milk agent. This colony was started in 1929 from 
mice kindly  provided  by  Dr.  A.  Lacassagne,  and  is 
locally designated  as  the  Paris  strain.  Three  to  five 
thousand  mice are maintained  in this colony and  the 
incidence of mammary adenocarcinoma is 97 per cent 
in the females. 
All assays were performed in C57 black mice which 
were originally provided by E.  C.  McDowell of  Cold 
Spring Harbor, New York, and which have been main- 
tained at Columbia since  1929. This colony of approxi- 
mately  4000  animals  has  been  completely  free  of 
mammary  carcinoma since  1947. The environment of 
the colonies is meticulously controlled, and pedigrees of 
the mice in each colony are carefully maintained. The 
milk preparations  were injected intraperitoneally  (0.1 
ml.)  into 12 to 15 day-old females. 
Preparation of Milk.--Five ml. samples of RIII milk, 
expressed  by means of a special breast pump into ice- 
packed centrifuge tubes were centrifuged at 1500 R.V.~. 
in  an  International  Equipment  Company,  Boston, 
trunnion cup head for I hour while under refrigeration. 
The milk was removed with a  syringe and long needle, 
leaving the cream and a small pellet in the  centrifuge 
tube, Care was taken always to keep the milk cold. After 
filtering, irradiating, or allowing to diffuse as described 
below,  the samples were diluted in Tyrode's solution 
which  contained  2  per  cent  serum  from  C57  mice, 
1000 units/ml, penicillin G and a  trace of phenol red. 
The serum was added to coat the glassware used and 
thus prevent the loss of the milk agent by its adherence 
to the glass at the higher dilutions. The following dilu- 
tions  werc  used:  10  -2,  10  -8,  10  -5,  10  -7,  and  10  -°. 
Tumors  were  occasionally  obtained  at  all  dilutions 
with many more at the lower dilutions. However, for 
convenient presentation  in  the  tables,  the  data  have 
been pooled for all dilutions in each experiment. 
Electron microscopy on sections of cultured tumors 
is included in this report. The procedure is described in 
the succeeding article. 
RESULTS 
Filtration of Milk through Gradocol Membranes.-- 
Gradocol membranes,  made according  to Elford's 
(13,  14) specifications and calibrated  by  the  man- 
ufacturer  were  obtained  from  Gallenkamp,  Ltd., 
London. The filtration process was hastened either 
by evacuating the receiving chamber or by apply- 
ing 15 pounds of pressure from a  nitrogen tank  to 
the reservoir. The  results  recorded  in Table  I  in- 
dicate that  pores of intermediate size prevent  the 
passage  of  activity  more  effectively  than  did 
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10 to 200 m#,  the pores were about twice as large 
as the particles passing them. 
Ionizing  Irradiation.--The  determination  of 
size of active areas by this method involves prob- 
ability considerations,  the  theory  and application 
of  which  have  already  been  amply  documented 
(15).  In our experiments 4  mev.  deuterons in  the 
cyclotron  were  employed  to  bombard  samples  of 
frozen-dried RIII milk. 0.05 ml. of milk from which 
the cream had been removed was placed on each of 
12 glass coverslips which were affixed  to  a  6  inch 
diameter brass disc later to go into the cyclotron. 
The disc, precooled with dry ice, was  then  evacu- 
ated for 2 to 3 hours while remaining in an ice chest 
or  sometimes  for 1/~  hour  at  room  temperature 
before  transferring  to  the  ice  chest.  The  disc 
was quickly transferred from the vacuum desicca- 
tor to the high vacuum of the cyclotron where the 
temperature was from 30 to 35°C. Nine of the glass 
coverslips holding the dried milk were then irradi- 
ated, one at a  time. Three served as controls. Three 
different doses of irradiation were used,  groups of 
3  coverslips being given the same dose.  The discs 
were  then carried from New Haven to New  York 
where they were kept cold until the following day, 
TABLE  I 
Filtration  through  Gradocol Membranes 
Whole  milk--unfiltered .............. 
Passing membranes with 780 m# pores.. 
......  160  ....  .. 
....  "  100  ....  .. 
......  38  ....  .. 
Residue held on membrane .......... 
No.  Tumor 
nice  inci- 
locu- 
ated  dence 
per cent 
42  53 
78  58 
46  4 
44  0 
45  11 
36  5 
12  50 
TABLE  II 



























* 1 beam-see.  =  101° deuterons/cm3. 
TABLE  III 
Deuteron  Irradiation  of Versene-Treated  Milk 
Irradiation  Minimum  siz,  destroyed 
beam-see,  mlz 
180  30 
14  100 
4  200 
0  Infinite 
Wet*  ~ versene ........ 


















* Control milk, not frozen-dried. 
when they were dissolved in the diluting phosphate 
buffered  saline  (pH  7.4)  and  inoculated  into  the 
12  to  15  day-old  female C57  mice. The results of 
these assays are recorded in Table II along with the 
calculated doses of irradiation sufficient to destroy 
99.9 per cent of the particles of different cross-sec- 
tional  areas.  The  number  of  tumors  obtained  in 
our C57 test mice is not very large, but these assays 
are to be evaluated against the knowledge that in 
11  years  with  a  colony  of  more  than  4000  mice 
there  has  not  been  a  single  spontaneous  tumor. 
There is no significant difference in the assay  data 
for the irradiation calculated to inactivate the  100 
and the 200 m/z particles and there was one  tumor 
even for  the high radiation dose  calculated  to  in- 
activate 30 m/z particles. In these experiments  the 
control samples  that went  into  the  cyclotron  but 
received  no  irradiation produced  no  tumors.  The 
reason for this is not understood. 
Chelation.--In  working  with  RIII  milk  a  few 
years  ago,  Dr.  Otto  Plescia  found  that  defatted 
milk  could  be  clarified  by  adding  a  trace  of  the 
chelating agent, versene3 Dispersions of untreated 
milk  (cream  removed)  yield  the  type  of  electron 
micrograph illustrated in Fig.  1. There are numer- 
ous  spherical  particles  having  a  wide  range  of 
sizes. After adding 5  per cent of a  0.15 M versene 
solution to  the milk, no particles larger than 5  to 
10 m/z can be found in  the usual dispersion,  as is 
illustrated in Fig.  2. However, the versene-treated 
milk remains active in producing tumors, and par- 
ticles varying in size from 20 to 100 rapt can be seen 
in  dispersions  after  the  milk  is  concentrated  by 
ultracentrifugation  (Fig.  3).  Chelated  milk  was 
subjected  to  the  cyclotron  experiments  with  re- 
1 Trisodium N-hydroxyethylethylenediaminetriacetic 
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TEXT-FIG. 1.  Diagram of diffusion  cell with many displaceable sections for isolating samples.  Concentration 
curves for spherical electrically neutral particles of two different sizes after diffusing for 72 hours at I°C. are shown 
at right along with the formulae for calculating them. 
R, the gas constant, 8.3  N  107 ergs per degree per mole 
T, absolute temperature 
N, Aragadro's constant, 6.02 X  10  ~ 
7, coefficient  of viscosity in poises 
r, the radius of the particle in centimeters 
sults  which  indicate  no  change  in  size,  but  the 
total frequency of tumors is greater, as is indicated 
by the data of Table III. The tumor incidence was 
lower, however, for the control milk that was  not 
dried. 
Di~usion.--The other  procedure  that  we  have 
used  in  determining  particles  size  is  that  of  free 
diffusion. If the agent-bearing milk is placed in the 
bottom part of a  cell and overlaid with a  buffer of 
suitable  pH  and  ionic  strength,  thermal  activity 
will cause the molecules and particles of the under- 
lying solution to diffuse up into the overlying solu- 
tion. The rate of mixing is a function of the size and 
shape of particles.  For these experiments a  special 
cell,  illustrated  in  Text-fig.  1,  with  many  sliding 
ground  glass plates,  2  and  3  mm.  thick,  was con- 
structed. ~ The channel of the bottom  section plus 
that of a  single plate was filled with defatted milk 
diluted  with  2  parts  of buffer pH  7.4.  The plate, 
sealed with silicone grease, was then displaced thus 
We are grateful to Mr. Emil Maier of the Pyrocell 
Manufacturing  Company,  New  York,  for  the  con- 
struction of this special diffusion cell. 
sealing the milk in the bottom. The excess milk was 
removed  from  the  channel  of  the  covering plate 
and  the channel was thorougly washed and rinsed. 
Six more  plates  were  then  added  and  filled  with 
buffer. The assembly was placed in a  thermostatic 
bath  at  I°C.  and  after  being  allowed  to  reach 
thermal  equilibrium  the  plates  were  aligned  with 
the bottom part of the cell. The initial very sharp 
boundary  was  allowed  to  diffuse  for  72  hours, 
whereupon  the channel was segmented into many 
small sections  by  displacing  consecutive plates  in 
opposite directions. It is possible to calculate theo- 
retically the concentration of particles in the vari- 
ous sections of the cell for spheres of different di- 
ameters  (16).  Curves for particles of two different 
sizes are plotted  in  the graph  of Text-fig.  1.  At 6 
mm. above the boundary  the concentration of  100 
m/z  spheres  in  72  hours  should  be  4  X  10  -4  the 
original concentration,  Co, whereas at  11  mm.  the 
concentration  should  be 3  X  10-1°Co.  For spheres 
of 10 m/z a second curve is obtained. At 11 mm. the 
concentration  should  be  0.024  Co.  The  results  of 
the  assays  in  mice  are  shown  in  Table  IV.  The MOORE,  LASFARGUES, MURRAY, HAAGENSEN, AND  POLLARD  89 
highest  tumor  incidence is  found  in  the first  sec- 
tion,  but  there  is some activity in sections  6  to 8 
ram.  above  the  boundary.  This  same  experiment 
was repeated with milk clarified with versene, the 
results being recorded in Table V. Since all samples 
taken from the diffusion cell were injected into the 
mice at dilutions of 10  -3 or greater,  the concentra- 
tions  become extremely low for  100  mtz particles. 
Clearly  there  is  no  correlation  between  the  theo- 
retical concentrations  and  the number  of carcino- 
mas  obtained;  but  since with  the  versene-treated 
TABLE  IV 
Diffusion  of Activity in RIlI  Milk  after 72 
Hours at 1.0°C. 
Calculated  concentration*  for 













(Diff.  coefficient 
6  X  10  -s) 
3 X  10  -l° Co 
4  X  10  -4  " 
1 X  10  -~  " 
0.13  " 
0.5  " 
1.0  " 
10 m# (Diff. 
coefficient 
6  X  10  -7 
0.024 Co 
0.18  " 
0.25  " 
0.36  " 
0.5  " 
1.0  " 
NO. 
mice  Tu- 
per 
cent 











* The  small  samples  removed  from  the  cell  were 
diluted  10  -a before assay,  making  the  total dilutions 
greater than the values given. 
TABLE V 
Diffusion  of Activity in  Versene-Treated  Rill 















6 X  10  -s) 
5 X  10  -l' Co 
3 X  10  -7  " 
4 X  10  -4  " 
4 X  10  -s  " 
0.5  " 
1.0  " 
i 
10 m~ (Diff. 
coefficient 
6  X  10-D 
0.017 Co 
0. 056  " 
0.18  " 
0.29  " 
0.5  " 
1.0  " 
Assays 
No. 
nice  Tu- 




17  5.9 
26  3.8 
31  6.5 
31  0 
20  10.0 
24  29.2 
* The  small  samples  removed  from  the  cell  were 
diluted  10  -a  before assay,  making  the  total  dilutions 
greater than the values given. 
milk  tumors  are produced  by the contents  of sec- 
tions above the location expected for  100  m# par- 
ticles,  activity  must  be  associated  with  smaller 
particles,  as  was  also  indicated  by  filtration  and 
irradiation. The highest carcinoma-producing dilu- 
tion obtained for RIII milk has been  10  -i°. There- 
fore,  the  milk  agent  cannot  consist  only  of  par- 
ticles as large as  100  m#. 
DISCUSSION 
The results of the several experiments described 
above do not  lead to an  easy description of the 
milk agent. As has  always been the  case in  the 
many attempts  to characterize this agent, the re- 
sults  are  sometimes erratic  and  inconsistent.  It 
has  been  well  established,  however,  that  the 
milk agent is not  the only influence entering into 
the  development  of  the  mammary  carcinomas, 
but  that  other  factors  such  as  heredity  and  hor- 
mones  are  also  determinants  (17).  Still  other 
entities,  as  yet  obscure,  may enter  into the proc- 
ess  as  well.  In  making  the  assays  we  are  con- 
trolling  only  one  variable;  i.e.,  the  amount  of 
milk  inoculated.  We  are  able  to  control  the 
amount  of  ionizing  irradiation  used  or  the  size 
of pores  in  the  filter  membranes,  but  we  do  not 
know  all  the  effects  that  irradiation  or  filtra- 
tion  have  on  the  milk.  Nor  do  we  have  knowl- 
edge  of  the  hormonal  status  of  the  animal  or 
the intricacies of its genetics. At this point not all 
of  the  inconsistencies  can  be unequivocally clari- 
fied. We believe, however,  that  some of  them  can 
be  explained  by  assuming  that  the agent  is  com- 
plex in nature,  existing in two different sizes, and 
that there is an inhibitor capable of destroying one 
form of the agent. 
Inhibitor  in  Milk.--In  both the diffusion experi- 
ments,  whether  versene  was  or  was  not  used, 
there  was  a  location  in  the  column  3  to  6  ram. 
above  the  original  boundary  where  the  activity 
fell to zero and  then reappeared  at a  higher level. 
Again,  in  the  filtration  experiments  the  material 
passing  through  100  m# pores showed no activity 
whereas  that  passing  smaller  pores  did.  Further- 
more,  in  the  deuteron  irradiation  experiments 
unirradiated  milk  produced  fewer  tumors  than 
did  samples  receiving  intermediate  doses  of 
irradiation.  Such  results  might  be  explained  by 
assuming  the  presence  of  an  inhibitor  which 
diffuses,  filters,  and  responds  to  irradiation  at  a 
different  rate  from  the  tumor-producing  agents. 
Indeed,  if it is assumed  that  the activity is asso- 90  MOUSE  MAMMARY TUMOR AGENT 
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TEXa'-FIo. 2.  Schematic diagrams illustrating the effects of filtration, ionizing irradiation, and diffusion on the 
three assumed active particles in the milk of high-breast-cancer, Rill strain mice. The first diagram indicates the 
particles passing through membranes with different average pore diameters, and the third indicates roughly the 
maximum relative height to which the different sized particles rise after diffusing for a period of time from the 
originally sharp boundary. 
TABLE VI 
Activity of Rill Milk as Influenced  by 
Treatment 
Treatment  inoculated  No. mice  Tumors 
per cent 
Untreated ...............  I  17  23.5 
Chymotrypsin (10 rain.)., .I  75  49,5 
Chymotrypsin (2 hrs.) .... I  28  46.4 
From reference 6 
Untreated ...............  382  6.3 
Versene-treated ..........  289  12.8 
From all deuteron irradiation  experiments includ- 
ing Tables II and III 
ciated  with  particles  of  two  distinct  sizes  and 
that  there is an "inhibitor" having an intermedi- 
ate  size  which  reacts  with  only  the  smaller  of 
the milk-agent particles, the data can, in general, 
be explained (see Text-fig. 2). 
In  filtration,  for  instance,  membranes  with 
large  pores  allow  all  three  particle  sizes  to  pass. 
Membranes  with  intermediate  sized  pores  (100 
m/z)  retain  only  the  larger  milk  agent,  passing 
the  "inhibitor"  and  the  smaller  agent,  which  is 
then  unable  to  produce  tumors.  Small  pores, 
however,  retain the  "inhibitor" leaving the  small 
agent undestroyed. 
Similarly,  in  free  diffusion  the  larger  agent 
is  confined to  the  lower  sections of  the  diffusion 
cell;  whereas  a  little  higher  there  is  only  the 
small  agent  and  "inhibitor"  which  give  zero 
activity;  slightly  higher  still,  the  small  agent 
alone is found with a  return of activity. 
In  the  deuteron  irradiation  experiments  the 
active  area  as  determined  by  the  irradiation 
would  be  the  same  for  both  the  large  and  the 
small  agent,  because  the  activity  may  be  asso- 
ciated  with  only the  core  of  the  larger  particle. 
Here  we  find  the  "inhibitor"  being  destroyed 
by  small  doses  of  irradiation  with  the  accom- 
panying  increase  in  tumor  incidence,  whereas  a 
large  dose  of irradiation destroys  also  the  agent. 
The  sizes of  these  assumed particles would seem 
to be as follows: large agent, 90 to  120 m/z; small 
agent, 15 to 35 m/z; and the inhibitor, 40 to 60 m/z. 
Treatment  with  chymotrypsin  and  with  versene 
seems  to  stimulate  the  tumor-inducing activities 
of milk, as is demonstrated  in Table VI. Drying 
in the presence of versene seems also  to  increase 
the  activity  of  the  agent  as  is  demonstrated  in 
Table III. The samples that went into the cyclo- 
tron produced more carcinomas than the controls 
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The  nature  of  the  "inhibitor"  is  not  known, 
but its  existence was  suggested  as  early as  1944 
because  extracting with  petroleum  ether  seemed 
to  increase  the  activity of  the  milk agent  (27). 
It  is  possible  that  the  "inhibitor"  is  either  an 
enzyme or an antibody. In order to fit the filtra- 
tion, irradiation, and diffusion data the size would 
have  to  be  unusually large,  but  both  of  these 
functions are  known to  be  sometimes associated 
with large molecular complexes. 
Structure  of Milk  Agent.--The  hypothesis  that 
the  mammary tumor agent exists  in  two  differ- 
ent  sizes  is  supported  by previous  data,  as  ob- 
served  above,  and  the  actual  appearance  of  the 
milk  agent  is  believed  to  be  represented  in  the 
electron  micrograph  of  Figs.  4  to  7.  The  char- 
acteristic structure seen here  consists of  a  dense 
body, a  nucleoid (18),  20  to  35  m/z in diameter 
contained within a membranous sac 90 to 120 m# 
(occasionally larger)  in diameter. The membrane 
forming the sac  appears to be of  the same struc- 
ture  and  density as  the  cell  membrane. It  is  8 
to  10 m/z thick.  Aside from the nucleoid the  sac 
does not contain any other structure; usually the 
nucleoid is near or in contact with the sac.  Occa- 
sionally a  sac  contains more  than  one  nucleoid 
(Fig.  5).  The  membrane is  designated  as  a  sac 
because  there  is considerable  variation  in  its 
size  and  shape  and it  does  not seem  to  be rigid 
enough  to  be  designated  as  a  shell  or  capsule. 
In  looking at  cultured  epithelial sheets  of  C3H 
tumors  placed  directly  in  the  electron  micro- 
scope  without  embedding and  sectioning, Porter 
and Thompson  (5)  observed  the presence of  the 
nucleoid  and  reported  that  "in  gold-shadowed 
preparations it is possible in some  cases  to  note 
that  the central dense portion protrudes above a 
flattened border," indicating that the dehydrated 
sac  had  collapsed  over  the  more  solid  nucleoid. 
The size range of the nucleoid reported by Porter 
and  Thompson was  necessarily larger  than  that 
seen in the profiles  obtained from sections (Figs. 
4  to 7)  because their measurements included also 
the  folded  sac  membranes.  Their  measurements 
ranged from 50 to 95 m/z for the internal body and 
from  90  to  200  m/~ for  the  over-all particle,  the 
latter also being larger due to flattening, because 
their specimens were  not embedded and the sacs 
collapsed  and  spread  over  a  greater  area  upon 
drying. 
Passey and his collaborators (4)  were  probably 
dealing with  only  the  nucleoid of  this  particle. 
They  used  petroleum  ether  to  extract  frozen- 
dried  tissues  before  extracting  the  milk  agent 
with  distilled  water.  Furthermore,  they  usually 
incubated  the  water  extract  with  trypsin. They 
state  (reference  2 page 402)  that "the preponder- 
ance of particles no larger  than about 30  m/~ in 
the  extracts  of  high-breast-cancer-strain tissues 
and  their  comparative  absence  from  extracts  of 
low-breast-cancer-strain  tissues  indicates  that 
such  particles  are  a  characteristic  feature  of 
high-breast-cancer-tissues."  It  is  possible  that 
the  ether  and  trypsin  treatment  destroyed  the 
sac  and  that  the  centrifugation  and  filtration 
yielded a fairly pure preparation of nucleoids. 
Graft et al.  (6),  using milk as the source of the 
agent, extracting not with ether but by treating 
with  chymotrypsin, and  purifying by  means  of 
differential centrifugation, obtained a  preparation 
which was predominantly the size of whole parti- 
cles.  Similar preparations of  milk  from  the  C57 
noncancerous mice did  not provide any particles 
at all when examined in the analytical ultracentri- 
fuge or the electron microscope. 
In spite of the fact that not much reliance can 
be  placed  on  these  early  experiments,  as  was 
pointed out  by Howatson  (19),  they at  least do 
not  conflict with  the  present  hypothesis  nor  in 
light  of  it,  with  each  other.  Much  more  experi- 
mental work needs to be done, however, to clarify 
results  obtained  by  different  preparative  proce- 
dures. 
The Nature of the Nucleoid.--The recent experi- 
ments  of  Schramm  (20),  Fraenkel-Conrat  (21), 
Colter  (22),  Alexander  (23),  and  others  have 
shown  that  nucleic acids  from  viruses  are  able 
to  carry  the  activity of  the  virus. Latarjet  (24) 
has  presented  evidence  that  nucleic  acid  from 
leukemic  tissues  of  Ak  mice  inoculated  into 
newborn isologous animals accelerated the appear- 
ance  of  leukemia  and  in  some  cases  caused  a 
variety of malignant tumors which never existed 
in  the  donors  of  the  extract.  Epstein  (25) has 
demonstrated  that  under  certain  conditions the 
central  bodies  of  Rous  sarcoma  virus  particles 
can be destroyed by incubating with ribonuclease. 
Pollard  (15) has  shown  that  the  active elements 
of  a  number  of  viruses  are  contained  within  a 
much larger  shell.  By  analogy the  nucleoids de- 
scribed are believed to represent the active nucleic 
acid or nucleoprotein of the milk agent. 
All of our experiments indicate that most of the 
activity is associated  with large particles,  but in 
almost every experiment activity is  found  to  be 
associated  also  with  small particles.  In  working 92  MOUSE  MAMMARY TUMOR AGENT 
with influenza virus Bourdillon (26) reported that 
its  infectivity  was  associated  with  two  distinct 
diffusion rates.  One  represented  a  particle  quite 
small,  probably  about  6  m/~;  the  other  a  large 
particle  over  100  m/~  in  diameter.  The  small 
particles  were  found  to  be  labile,  whereas  the 
large ones were more stabile. Similarly, the naked 
nucleic acids of TMV (20, 21), neurotropic viruses 
(22),  and polio  (23)  virus has  been  found  to  be 
more labile than the whole particle. In our experi- 
ments the small milk agent seems to be vulnerable 
to  certain  components  of  the  milk  (the  "inhibi- 
tor"),  whereas  the  large  agent  with  outer  mem- 
brane is more stabile. 
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EXPLANATION OF PLATES 
PLATE 34 
Microdroplets of milk were dispersed with a nebulizer before shadowing with chromium. 
FIG. 1. Mouse milk (RIII). The cream was removed by low speed centrifugation. X  34,000. 
FIG. 2. Same as Fig. 1 except that 0.05 m]. of a 0.15 M versene solution was added to 1 ml. of the milk. )< 21,000. 
FIG. 3. Sample from bottom of centrifuge tube after centrifuging the versene-treated milk for 1 hour at 40,000 
R.P.M. (approximately 100,000 g). X  34,000. THE  JOURNAL OF 




(Moore et al.:  Mouse mammary tumor agent) PLATE 35 
For details of electron microscopy see the following article. 
FIG.  4. RIII  tumor grown in tissue culture for 14 days.  Many particles consisting of sac and nucleoid are seen 
near the cell membrane and in the wide intercellular space. They appear to be irregular elipsoids with their major 
axes all pointing the same direction. This indicates that they were spherical but have been deformed by the micro- 
tome knife. Their outer diameters average 95 to  100 m#, the membranes being about l0 m/~ thick. The nucleoids 
are dimcult to measure. They are usually most dense at their centers and fade away at the periphery, although a 
few reveal a  granular nature (arrows).  They also show variation in size, and some, M, seem to have exceedingly 
delicate membranes. Their mean diameters wouk| seem to be about 25 to 30 m#. Interdispersed with viral particles 
are also many smaller bodies which have a  lesser density than the nucleoids. The viral bodies seem to be formed 
at  the cell membrane by a  budding process. At the lower left the cell membrane is particularly  thick and dense. 
The presumed initial stage of particle formation is represented at A, and a later stage is seen at B. Particles C and 
D  appear to have just been released.  (See text of following article.)  X  90,000. THE  JOURNAL OF 




(Moore el al.: Mouse mammary tumor agent) PLATE 36 
Fro.  5. Another section from the same tissue as in Fig. 4  showing a  small intercellular lumen with many micro- 
villi and characteristic virus particles. Here there is a  greater variation in particle size with some of the particles 
containing double nucleoids (arrows). Many RNP granules can be seen in cytoplasm. These granules are 10 to  15 
m# in size and many, as at R, are not associated with the endoplasmic reticulum. THE  JOURNAL  OF 
BIOPHYSICAL AND BIOCHEMICAL 
CYTOLOGY 
PLATE  36 
VOL. 5 
(Moore eta/.: Mouse mammary tumor agent) PLATE 37 
FIG.  6.  Ten-day culture showing portion of a  large intercellular space completely surrounded by degenerating 
cells whose cytoplasms are granular. Neither mitochondria nor nuclei are well defined. Interdigitating cell mem- 
branes can only faintly be seen at cm.  A few partially formed viral particles are evident (arrows). Numerous small 
vesicles, 65 to 70 m#, are apparent at upper left.  X  30,000. 
FIG.  7. Micrograph of section from the same preparation as  Fig.  6, including parts of three cells. These cells are 
not so necrotic as those of Fig. 6, and the formation of many particles is evident. The bodies which appear to be 
in the cytoplasm are actually on the surface of the cell because the surface is almost parallel with the plane of sec- 
tion. Similarly many of those that appear to be  in  the  intercellular  space are on irregularities  of  the cell  surface 
just caught in the section. This, therefore, depicts an unusual display of viral synthesis. Assumed stages in develop- 
ment are marked alphabetically, A  to D. X  43,000. THE  JOURNAL OF 




(Moore eta/.: Mouse mammary tumor agent) 